Search Results

You searched for all publications:

with publication states 'Published (Approved)'

Search Again...

These results only include publications that have been reviewed and processed by Diamond Light Source. To also view papers that have not yet been processed click here.

You can use the folder icon under Actions to collate papers as required. You can then click on View Folder in the left-hand navigation to review and/or download your folder.

Exact matches
Related results

9 items found (0 items not approved), displaying all items.1

Instruments / Technical Area	Publication Details	Published
I02-Macromolecular Crystallography I04-Macromolecular Crystallography	From 1,4-disaccharide to 1,3-glycosyl carbasugar: Synthesis of a bespoke inhibitor of family GH99 endo-α-mannosidase Dan Lu , Sha Zhu , Lukasz F. Sobala , Ganeko Bernardo-Seisdedos , Oscar Millet , Yongmin Zhang , Jesus Jiménez-Barbero , Gideon J. Davies , Matthieu Sollogoub Organic Letters DOI: 10.1021/acs.orglett.8b03260 Diamond Proposal Number(s): [9948] Show Abstract ▼ Abstract: Understanding the enzyme reaction mechanism can lead to the design of enzyme inhibitors. A Claisen rearrangement was used to allow conversion of an α-1,4-disaccharide into an α-1,3-linked glycosyl carbasugar to target the endo-α-mannosidase from the GH99 glycosidase family, which, unusually, is believed to act through a 1,2-anhydrosugar “epoxide” intermediate. Using NMR and X-ray crystallography, it is shown that glucosyl carbasugar α-aziridines can act as reasonably potent endo-α-mannosidase inhibitors, likely by virtue of their shape mimicry and the interactions of the aziridine nitrogen with the conserved catalytic acid/base of the enzyme active site.	Nov 2018
I03-Macromolecular Crystallography	Structural and mechanistic insights into the catalytic-domain-mediated short-range glycosylation preferences of galnac-t4 Matilde De Las Rivas , Earnest James Paul Daniel , Helena Coelho , Erandi Lira-Navarrete , Lluis Raich , Ismael Compañón , Ana Diniz , Laura Lagartera , Jesús Jiménez-Barbero , Henrik Clausen , Carme Rovira , Filipa Marcelo , Francisco Corzana , Thomas A. Gerken , Ramon Hurtado-Guerrero Acs Central Science DOI: 10.1021/acscentsci.8b00488 Diamond Proposal Number(s): [10121] Open Access Show Abstract ▼ Abstract: Mucin-type O-glycosylation is initiated by a family of polypeptide GalNAc-transferases (GalNAc-Ts) which are type-II transmembrane proteins that contain Golgi luminal catalytic and lectin domains that are connected by a flexible linker. Several GalNAc-Ts, including GalNAc-T4, show both long-range and short-range prior glycosylation specificity, governed by their lectin and catalytic domains, respectively. While the mechanism of the lectin-domain-dependent glycosylation is well-known, the molecular basis for the catalytic-domain-dependent glycosylation of glycopeptides is unclear. Herein, we report the crystal structure of GalNAc-T4 bound to the diglycopeptide GATGAGAGAGTTPGPG (containing two α-GalNAc glycosylated Thr (T*), the PXP motif and a “naked” Thr acceptor site) that describes its catalytic domain glycopeptide GalNAc binding site. Kinetic studies of wild-type and GalNAc binding site mutant enzymes show the lectin domain GalNAc binding activity dominates over the catalytic domain GalNAc binding activity and that these activities can be independently eliminated. Surprisingly, a flexible loop protruding from the lectin domain was found essential for the optimal activity of the catalytic domain. This work provides the first structural basis for the short-range glycosylation preferences of a GalNAc-T.	Sep 2018
I03-Macromolecular Crystallography	Molecular recognition of a Thomsen-Friedenreich antigen mimetic targeting human galectin-3 Sabrina Santarsia , Ana Sofia Grosso , Filipa Trovão , Jesús Jiménez-Barbero , Ana Luisa Carvalho , Cristina Nativi , Filipa Marcelo Chemmedchem DOI: 10.1002/cmdc.201800525 Diamond Proposal Number(s): [16609] Show Abstract ▼ Abstract: Overexpression of the Thomsen‐Friedenreich (TF) antigen in cell membrane proteins occurs in 90% of adenocarcinomas. Additionally, the binding of the TF‐antigen to human galectin‐3 (Gal‐3), also frequently overexpressed in malignancy, promotes cancer progression and metastasis. In this context, structures that interfere with this specific interaction display the potential to prevent cancer metastasis. Herein, a multidisciplinary approach, combining the optimized synthesis of a TF‐antigen mimetic with NMR, X‐ray crystallography methods and isothermal titration calorimetry assays has been employed to unravel the molecular structural details that govern the Gal‐3/TF‐mimetic interaction. The TF‐mimetic presents a binding affinity for Gal‐3 similar to the TF‐natural antigen and retains the binding epitope and the bioactive conformation observed for the native antigen. Furthermore, from a thermodynamic perspective a decrease in the enthalpic contribution was observed for the Gal‐3/TF‐mimetic complex, however this behaviour is compensated by a favourable entropy gain. From a structural perspective, these results establish our TF‐mimetic as a scaffold to design multivalent solutions to potentially interfere with Gal‐3 aberrant interactions and likely be used to hamper Gal‐3‐mediated cancer cells adhesion and metastasis.	Aug 2018
I04-Macromolecular Crystallography	Structural analysis of a GalNAc-T2 mutant reveals an induced-fit catalytic mechanism for GalNAc-Ts Ramon Hurtado-Guerrero , Matilde De Las Rivas , Helena Coelho , Ana Diniz , Erandi Lira-Navarrete , Ismael Compañón , Jesús Jiménez-Barbero , Katrine T. Schjoldager , Eric P. Bennett , Sergey Y. Vakhrushev , Henrik Clausen , Francisco Corzana , Filipa Marcelo Chemistry - A European Journal DOI: 10.1002/chem.201800701 Diamond Proposal Number(s): [10121] Show Abstract ▼ Abstract: The family of polypeptide GalNAc‐transferases (GalNAc‐Ts) orchestrates the initiating step of mucin‐type protein O‐glycosylation by transfer of GalNAc moieties to serine and threonine residues in proteins. Deficiencies and dysregulation of GalNAc‐T isoenzymes have been found to be related to different diseases. Recently, we have demonstrated that an inactive GalNAc‐T2 mutant (F104S), which is not located at the active site, induces low levels of high‐density lipoprotein cholesterol (HDL‐C) in humans. Here, we have deciphered the molecular basis for F104S mutant inactivation. Saturation transfer difference NMR experiments demonstrate that the mutation induces loss of binding to peptide substrates. The analysis of the crystal structure of the F104S mutant bound to UDP‐GalNAc, combined with molecular dynamics (MD) simulations, has revealed that the flexible loop is disordered and displays larger conformational changes in the mutant enzyme than in the wild‐type (WT) enzyme. 19F‐NMR experiments reveal that the WT enzyme reaches the active state only in the presence of UDP‐GalNAc, providing compelling evidences that GalNAc‐T2 adopts an UDP‐GalNAc‐dependent induced‐fit mechanism. The F104S mutation precludes the enzyme to achieve the active conformation and concomitantly to bind peptide substrates. The present study provides new insights into the catalytic mechanism of the large family of GalNAc‐Ts and how these enzymes orchestrate protein O‐glycosylation.	Mar 2018
I03-Macromolecular Crystallography	The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences Matilde De Las Rivas , Erandi Lira-Navarrete , Earnest James Paul Daniel , Ismael Compañón , Helena Coelho , Ana Diniz , Jesús Jiménez-Barbero , Jesús M. Peregrina , Henrik Clausen , Francisco Corzana , Filipa Marcelo , Gonzalo Jiménez-Osés , Thomas A. Gerken , Ramon Hurtado-Guerrero Nature Communications 8 DOI: 10.1038/s41467-017-02006-0 Diamond Proposal Number(s): [10121] Open Access Show Abstract ▼ Abstract: The polypeptide GalNAc-transferases (GalNAc-Ts), that initiate mucin-type O-glycosylation, consist of a catalytic and a lectin domain connected by a flexible linker. In addition to recognizing polypeptide sequence, the GalNAc-Ts exhibit unique long-range N- and/or C-terminal prior glycosylation (GalNAc-O-Ser/Thr) preferences modulated by the lectin domain. Here we report studies on GalNAc-T4 that reveal the origins of its unique N-terminal long-range glycopeptide specificity, which is the opposite of GalNAc-T2. The GalNAc-T4 structure bound to a monoglycopeptide shows that the GalNAc-binding site of its lectin domain is rotated relative to the homologous GalNAc-T2 structure, explaining their different long-range preferences. Kinetics and molecular dynamics simulations on several GalNAc-T2 flexible linker constructs show altered remote prior glycosylation preferences, confirming that the flexible linker dictates the rotation of the lectin domain, thus modulating the GalNAc-Ts' long-range preferences. This work for the first time provides the structural basis for the different remote prior glycosylation preferences of the GalNAc-Ts.	Dec 2017
I04-Macromolecular Crystallography	The use of fluoroproline in MUC1 antigen enables efficient detection of antibodies in patients with prostate cancer Víctor Jesús Somovilla , Iris Alicia Bermejo , Inês S. Albuquerque , Nuria Martínez-Sáez , Jorge Castro-López , Fayna Garcia Martin , Ismael Compañón , Hiroshi Hinou , Shin-Ichiro Nishimura , Jesús Jiménez-Barbero , Juan Luis Asensio , Alberto Avenoza , Jesús H Busto , Ramon Hurtado-Guerrero , Jesús M. Peregrina , Gonçalo J.l. Bernardes , Francisco Corzana Journal Of The American Chemical Society DOI: 10.1021/jacs.7b09447 Diamond Proposal Number(s): [10121] Open Access Show Abstract ▼ Abstract: A structure-based design of a new generation tumor-associated glycopeptides with improved affinity against two anti-MUC1 antibodies is described. These unique antigens feature a fluorinated proline residue, such as a (4S)-4-fluoro-L-proline or 4,4-difluoroproline, at the most immunogenic domain. Binding assays using bio-layer interferometry reveal 3-fold to 10-fold affinity improvement with respect to the natural (glyco)peptides. According to X-ray crystallography and MD simulations, the fluorinated residues stabilize the antigen-antibody complex by enhancing key CH/π interactions. Interestingly, a notable improvement in detection of cancer-associated anti-MUC1 antibodies from serum of patients with prostate cancer is achieved with the non-natural antigens, which proves that these derivatives can be considered better diagnostic tools than the natural antigen for this type of cancer.	Nov 2017
I02-Macromolecular Crystallography I04-1-Macromolecular Crystallography (fixed wavelength) I04-Macromolecular Crystallography I24-Microfocus Macromolecular Crystallography	Contribution of shape and charge to the inhibition of a family GH99 endo -α-1,2-mannanase Marija Petricevic , Lukasz F. Sobala , Pearl Fernandes , Lluís Raich , Andrew James Thompson , Ganeko Bernardo-Seisdedos , Oscar Millet , Sha Zhu , Matthieu Sollogoub , Jesús Jimenez-Barbero , Carme Rovira , Gideon J. Davies , Spencer J. Williams Journal Of The American Chemical Society DOI: 10.1021/jacs.6b10075 Diamond Proposal Number(s): [9948] Open Access Show Abstract ▼ Abstract: Inhibitor design incorporating features of the reaction coordinate and transition-state structure has emerged as a powerful approach for the development of enzyme inhibitors. Such inhibitors find use as mechanistic probes, chemical biology tools and therapeutics. Endo-α-1,2-mannosidases and endo-α-1,2-mannanases, members of glycoside hydrolase family 99 (GH99), are interesting targets for inhibitor development as they play key roles in N-glycan maturation and microbiotal yeast mannan degradation, respectively. These enzymes are proposed to act via an 1,2-anhydrosugar 'epoxide' mechanism that proceeds through a proposed unusual conformational itinerary. Here, we explore how charge and shape contribute to binding of diverse inhibitors of these enzymes. We report the synthesis of neutral dideoxy, glucal and cyclohexenyl disaccharide inhibitors, their binding to GH99 endo-α-1,2-mannanases, and their structural analysis by X-ray crystallography. Quantum mechanical calculations of the free energy landscapes reveal how the neutral inhibitors provide shape but not charge mimicry of the proposed intermediate and transition state structures. Building upon the knowledge of shape and charge contributions to inhibition of family GH99 enzymes, we design and synthesize α-Man-1,3-noeuromycin, which is revealed to be the most potent (KD 13 nM for Bacteroides xylanisolvens GH99 enzyme) inhibitor of these enzymes yet reported. This work reveals how shape and charge mimicry of transition state features can enable the rational design of potent inhibitors.	Dec 2016
I02-Macromolecular Crystallography I04-Macromolecular Crystallography	Deciphering the non-equivalence of serine and threonine o-glycosylation points: implications for molecular recognition of the Tn antigen by an anti-MUC1 antibody Nuria Martínez-Sáez , Jorge Castro-López , Jessika Valero-González , David Madariaga , Ismael Compañón , Víctor J. Somovilla , Míriam Salvadó , Juan L. Asensio , Jesús Jiménez-Barbero , Alberto Avenoza , Jesús H. Busto , Gonçalo J. L. Bernardes , Jesús M. Peregrina , Ramón Hurtado-Guerrero , Francisco Corzana Angewandte Chemie International Edition 54 (34), 9830 - 9834 DOI: 10.1002/anie.201502813 PMID: 26118689 Diamond Proposal Number(s): [10121, 8035] Open Access Show Abstract ▼ Abstract: The structural features of MUC1-like glycopeptides bearing the Tn antigen (α-O-GalNAc-Ser/Thr) in complex with an anti MUC-1 antibody are reported at atomic resolution. For the α-O-GalNAc-Ser derivative, the glycosidic linkage adopts a high-energy conformation, barely populated in the free state. This unusual structure (also observed in an α-S-GalNAc-Cys mimic) is stabilized by hydrogen bonds between the peptidic fragment and the sugar. The selection of a particular peptide structure by the antibody is thus propagated to the carbohydrate through carbohydrate/peptide contacts, which force a change in the orientation of the sugar moiety. This seems to be unfeasible in the α-O-GalNAc-Thr glycopeptide owing to the more limited flexibility of the side chain imposed by the methyl group. Our data demonstrate the non-equivalence of Ser and Thr O-glycosylation points in molecular recognition processes. These features provide insight into the occurrence in nature of the APDTRP epitope for anti-MUC1 antibodies.	Aug 2015
I03-Macromolecular Crystallography	Detection of tumor-associated glycopeptides by lectins: the peptide context modulates carbohydrate recognition David Madariaga , Nuria Martínez-Sáez , Víctor J. Somovilla , Helena Coelho , Jessika Valero-González , Jorge Castro-López , Juan L. Asensio , Jesús Jiménez-Barbero , Jesús H. Busto , Alberto Avenoza , Filipa Marcelo , Ramón Hurtado-Guerrero , Francisco Corzana , Jesús M. Peregrina Acs Chemical Biology 10 (3), 747 - 756 DOI: 10.1021/cb500855x PMID: 25457745 Diamond Proposal Number(s): [8035] Show Abstract ▼ Abstract: Tn antigen (α-O-GalNAc-Ser/Thr) is a convenient cancer biomarker that is recognized by antibodies and lectins. This work yields remarkable results for two plant lectins in terms of epitope recognition and reveals that these receptors show higher affinity for Tn antigen when it is incorporated in the Pro-Asp-Thr-Arg (PDTR) peptide region of mucin MUC1. In contrast, a significant affinity loss is observed when Tn antigen is located in the Ala-His-Gly-Val-Thr-Ser-Ala (AHGVTSA) or Ala-Pro-Gly-Ser-Thr-Ala-Pro (APGSTAP) fragments. Our data indicate that the charged residues, Arg and Asp, present in the PDTR sequence establish noteworthy fundamental interactions with the lectin surface as well as fix the conformation of the peptide backbone, favoring the presentation of the sugar moiety toward the lectin. These results may help to better understand glycopeptide–lectin interactions and may contribute to engineer new binding sites, allowing novel glycosensors for Tn antigen detection to be designed.	Dec 2014

Publications Database

Search Results

You searched for all publications:

Search Again...

Subject Areas (check all that apply) select all

Instruments used to collect data (check all that apply) select all

Collaborations involved (check all that apply) select all

Diamond Offline Facilities used

Relevant Technical Areas (check all that apply) select all

Menu for Anonymous User